Implementing Artificial Intelligence to Prevent Vision Loss From Diabetes

Enrolling by invitation · Not applicable

Conditions studied: Vision Disorders, Diabetes

In brief

This pragmatic clinical trial is being conducted to test the effectiveness of AI in improving screening and follow-up eye care compared to usual-care among patients with diabetes across 4 primary care clinics. This is an autonomous AI-based screening to detect diabetic eye disease at primary care visits.

Key facts

Study ID

NCT07559292

Run by

University of Wisconsin, Madison

People needed

1700

Starts

2026-02-15

Expected to finish

2027-02-01

Last updated by the study team

2026-04-30

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• Have a documented eye exam in the electronic health record within 12 months of the date of the primary care visit.
• Contraindication includes diagnosed with macular edema, severe non-proliferative retinopathy, proliferative retinopathy, radiation retinopathy, or retinal vein occlusion.
• Pregnant

Where it is running

• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.